tiprankstipranks
Trending News
More News >
BioRestorative Therapies (BRTX)
NASDAQ:BRTX
US Market

BioRestorative Therapies (BRTX) Financial Statements

Compare
211 Followers

BioRestorative Therapies Financial Overview

BioRestorative Therapies's market cap is currently $10.49M. The company's EPS TTM is $-0.33; its P/E ratio is -0.78; BioRestorative Therapies is scheduled to report earnings on November 12, 2025, and the estimated EPS forecast is $-0.38. See an overview of income statement, balance sheet, and cash flow financials.
Dec 24Dec 23Dec 22Dec 21Dec 20
Income Statement
Total Revenue$ 401.00K$ 145.80K$ 119.80K$ 46.00K$ 77.00K
Gross Profit$ 372.93K$ 145.80K$ 119.80K$ 46.00K$ 77.00K
Operating Income$ -11.56M$ -15.22M$ -18.97M$ -26.31M$ -2.75M
EBITDA$ -11.37M$ -14.97M$ -18.74M$ -26.22M$ -9.48M
Net Income$ -8.98M$ -10.42M$ -13.22M$ -44.30M$ -11.27M
Balance Sheet
Cash & Short-Term Investments$ 10.73M$ 11.07M$ 14.75M$ 21.03M$ 3.06M
Total Assets$ 12.28M$ 12.61M$ 16.43M$ 22.45M$ 4.35M
Total Debt$ 0.00$ 162.32K$ 301.64K$ 670.70K$ 4.79M
Net Debt$ -547.89K$ -722.06K$ -1.41M$ -20.36M$ 1.73M
Total Liabilities$ 3.75M$ 2.61M$ 6.14M$ 856.50K$ 5.68M
Stockholders' Equity$ 8.53M$ 10.00M$ 10.29M$ 21.60M$ -1.33M
Cash Flow
Free Cash Flow$ -8.34M$ -6.60M$ -6.35M$ -3.36M$ -1.96M
Operating Cash Flow$ -8.23M$ -6.43M$ -5.91M$ -3.33M$ -1.96M
Investing Cash Flow$ 514.53K$ 3.25M$ -13.40M$ -30.66K$ 0.00
Financing Cash Flow$ 7.38M$ 2.35M$ 0.00$ 21.32M$ 5.03M
Currency in USD

BioRestorative Therapies Earnings and Revenue History

BioRestorative Therapies Debt to Assets

BioRestorative Therapies Cash Flow

BioRestorative Therapies Forecast EPS vs Actual EPS